Arjo AB(0HQ8)
SEK --+0.00%
Reward47Moderate
Risk18Low
📊50%Data
Thin 3% profit margin · Revenue down 6% YoY
0HQ8
+0.0 · +0.00%
SEK · LSE
Arjo AB |
Earnings Deterioration
Market Cap:21.70Bn
ℹ️
Reward Rating
47
Moderate
Bottom 25% (model universe)
50% data coverage
ℹ️
Risk Rating
18
Low
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on 0HQ8 to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Arjo AB?

Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and the Pacific.

0HQ8 · Verdict

Moderate reward · low risk

0HQ8 stands out on cash flow and balance sheet, but watch the profitability signal.

Based on 75% data coverage

0HQ8 · Verdict

What’s working & what to watch

Strengths 3

  • Cash flow95/100

    Top decile vs peers

  • Balance sheet84/100

    Current ratio 1.54

  • Volatility65/100

    Above average

Watchouts 1

  • Profitability24/100

    4% return on equity

Model-based scoring. For information only — not financial advice.

What is Arjo AB?

Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and the Pacific. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, hygiene, prevention of pressure injuries and blood clots, and leg ulcer treatment and prevention, as well as for obstetric and cardiac diagnostics. The company is listed on the LSE in UK, with a market capitalisation of 21.70B.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (47)

The scoring profile indicates limited reward potential at this time, with valuation and growth offering the most support. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Company Information
SectorN/A
Market Cap21.70B
P/E RatioN/A
Dividend Yield1.72%
52 Week High35.6104
52 Week Low23.3865
Last AnnualDecember
IPO DateN/A
IncorporatedUK
Shares OutstandingN/A
No. of Employees7,000
IndustryN/A
ExchangeLSE
Beta0.747
CurrencySEK